Author: Christian Winkler
Publisher:
ISBN: 9789162853587
Category :
Languages : en
Pages : 169
Book Description
Toward a Restorative Therapy for Parkinson's Disease
Author: Christian Winkler
Publisher:
ISBN: 9789162853587
Category :
Languages : en
Pages : 169
Book Description
Publisher:
ISBN: 9789162853587
Category :
Languages : en
Pages : 169
Book Description
Restorative Therapies in Parkinson's Disease
Author: Patrik Brundin
Publisher: Springer Science & Business Media
ISBN: 0387328238
Category : Medical
Languages : en
Pages : 397
Book Description
In this exciting and timely book new approaches to repairing the parkinsonian brain are described by leading experts. Never in history has there been greater hope that novel experimental therapies can support significant restoration of brain function. This book gives an overview of the current state-of-the-art research for brain repair, what the challenges are and an indication of what research can provide for the next generation of people with Parkinson’s disease. The comprehensive chapters are geared to an audience of neuroscientists, neurologists, neurosurgeons and anyone interested in how findings in the research laboratory can effectively be transferred to the clinic.
Publisher: Springer Science & Business Media
ISBN: 0387328238
Category : Medical
Languages : en
Pages : 397
Book Description
In this exciting and timely book new approaches to repairing the parkinsonian brain are described by leading experts. Never in history has there been greater hope that novel experimental therapies can support significant restoration of brain function. This book gives an overview of the current state-of-the-art research for brain repair, what the challenges are and an indication of what research can provide for the next generation of people with Parkinson’s disease. The comprehensive chapters are geared to an audience of neuroscientists, neurologists, neurosurgeons and anyone interested in how findings in the research laboratory can effectively be transferred to the clinic.
Towards New Therapies for Parkinson's Disease
Author: David Finkelstein
Publisher: BoD – Books on Demand
ISBN: 9533074639
Category : Medical
Languages : en
Pages : 412
Book Description
Parkinson's disease (PD) is characterised clinically by various non-motor and progressive motor symptoms, pathologically by loss of dopamine producing cells and intraneuronal cytoplasmic inclusions composed primarily of ?-synuclein. By the time a patient first presents with symptoms of Parkinson's disease at the clinic, a significant proportion of the cells in the substantia nigra have already been destroyed. This degeneration progresses despite the current therapies until the cell loss is so great that the quality of normal life is compromised. The dopamine precursor levodopa is the most valuable drug currently available for the treatment of PD. However for most PD patients, the optimal clinical benefit from levodopa decreases around five to six years of treatment. The aim of the chapters of this book is to work towards an understanding in the mechanisms of degeneration and to develop disease modifying therapies.
Publisher: BoD – Books on Demand
ISBN: 9533074639
Category : Medical
Languages : en
Pages : 412
Book Description
Parkinson's disease (PD) is characterised clinically by various non-motor and progressive motor symptoms, pathologically by loss of dopamine producing cells and intraneuronal cytoplasmic inclusions composed primarily of ?-synuclein. By the time a patient first presents with symptoms of Parkinson's disease at the clinic, a significant proportion of the cells in the substantia nigra have already been destroyed. This degeneration progresses despite the current therapies until the cell loss is so great that the quality of normal life is compromised. The dopamine precursor levodopa is the most valuable drug currently available for the treatment of PD. However for most PD patients, the optimal clinical benefit from levodopa decreases around five to six years of treatment. The aim of the chapters of this book is to work towards an understanding in the mechanisms of degeneration and to develop disease modifying therapies.
Neurodegeneration and Neuroprotection in Parkinson's Disease
Author:
Publisher: Elsevier
ISBN: 0080537413
Category : Medical
Languages : en
Pages : 239
Book Description
Neuroscience Perspectives provides multidisciplinary reviews of topics in one of the most divers and rapidly advancing fields in the life sciences. Whether you are a new recruit to neuroscience, or an established expert, look to this series for 'one-stop' sources of the historical, physiological, pharmacological, biochemical, molecular biological, and therapeutic aspects of chosen research areas.
Publisher: Elsevier
ISBN: 0080537413
Category : Medical
Languages : en
Pages : 239
Book Description
Neuroscience Perspectives provides multidisciplinary reviews of topics in one of the most divers and rapidly advancing fields in the life sciences. Whether you are a new recruit to neuroscience, or an established expert, look to this series for 'one-stop' sources of the historical, physiological, pharmacological, biochemical, molecular biological, and therapeutic aspects of chosen research areas.
Towards New Therapies for Parkinson's Disease
Author: David Finkelstein
Publisher: IntechOpen
ISBN: 9789533074634
Category : Medical
Languages : en
Pages : 410
Book Description
Parkinson's disease (PD) is characterised clinically by various non-motor and progressive motor symptoms, pathologically by loss of dopamine producing cells and intraneuronal cytoplasmic inclusions composed primarily of ?-synuclein. By the time a patient first presents with symptoms of Parkinson's disease at the clinic, a significant proportion of the cells in the substantia nigra have already been destroyed. This degeneration progresses despite the current therapies until the cell loss is so great that the quality of normal life is compromised. The dopamine precursor levodopa is the most valuable drug currently available for the treatment of PD. However for most PD patients, the optimal clinical benefit from levodopa decreases around five to six years of treatment. The aim of the chapters of this book is to work towards an understanding in the mechanisms of degeneration and to develop disease modifying therapies.
Publisher: IntechOpen
ISBN: 9789533074634
Category : Medical
Languages : en
Pages : 410
Book Description
Parkinson's disease (PD) is characterised clinically by various non-motor and progressive motor symptoms, pathologically by loss of dopamine producing cells and intraneuronal cytoplasmic inclusions composed primarily of ?-synuclein. By the time a patient first presents with symptoms of Parkinson's disease at the clinic, a significant proportion of the cells in the substantia nigra have already been destroyed. This degeneration progresses despite the current therapies until the cell loss is so great that the quality of normal life is compromised. The dopamine precursor levodopa is the most valuable drug currently available for the treatment of PD. However for most PD patients, the optimal clinical benefit from levodopa decreases around five to six years of treatment. The aim of the chapters of this book is to work towards an understanding in the mechanisms of degeneration and to develop disease modifying therapies.
Towards New Therapies for Parkinson's Disease
Author: David Finkelstein
Publisher: IntechOpen
ISBN: 9789533074634
Category : Medical
Languages : en
Pages : 410
Book Description
Parkinson's disease (PD) is characterised clinically by various non-motor and progressive motor symptoms, pathologically by loss of dopamine producing cells and intraneuronal cytoplasmic inclusions composed primarily of ?-synuclein. By the time a patient first presents with symptoms of Parkinson's disease at the clinic, a significant proportion of the cells in the substantia nigra have already been destroyed. This degeneration progresses despite the current therapies until the cell loss is so great that the quality of normal life is compromised. The dopamine precursor levodopa is the most valuable drug currently available for the treatment of PD. However for most PD patients, the optimal clinical benefit from levodopa decreases around five to six years of treatment. The aim of the chapters of this book is to work towards an understanding in the mechanisms of degeneration and to develop disease modifying therapies.
Publisher: IntechOpen
ISBN: 9789533074634
Category : Medical
Languages : en
Pages : 410
Book Description
Parkinson's disease (PD) is characterised clinically by various non-motor and progressive motor symptoms, pathologically by loss of dopamine producing cells and intraneuronal cytoplasmic inclusions composed primarily of ?-synuclein. By the time a patient first presents with symptoms of Parkinson's disease at the clinic, a significant proportion of the cells in the substantia nigra have already been destroyed. This degeneration progresses despite the current therapies until the cell loss is so great that the quality of normal life is compromised. The dopamine precursor levodopa is the most valuable drug currently available for the treatment of PD. However for most PD patients, the optimal clinical benefit from levodopa decreases around five to six years of treatment. The aim of the chapters of this book is to work towards an understanding in the mechanisms of degeneration and to develop disease modifying therapies.
Towards Cell Replacement Therapy in Parkinson's Disease
Author:
Publisher:
ISBN: 9789187189364
Category :
Languages : en
Pages : 58
Book Description
Publisher:
ISBN: 9789187189364
Category :
Languages : en
Pages : 58
Book Description
Physical Therapy Management of Parkinson's Disease
Author: George I. Turnbull
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 232
Book Description
Covering physical therapy in Parkinson's disease, this book aims to provide the physical therapist with valuable information on the physiology and medical and surgical management of the disease entity. It also reviews past physical therapy management and discusses current and future practice.
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 232
Book Description
Covering physical therapy in Parkinson's disease, this book aims to provide the physical therapist with valuable information on the physiology and medical and surgical management of the disease entity. It also reviews past physical therapy management and discusses current and future practice.
Towards a Better Treatment of Parkinson's Disease
Author: Bradley Darryl Karain
Publisher:
ISBN:
Category : Dissertations, Academic
Languages : en
Pages : 166
Book Description
Publisher:
ISBN:
Category : Dissertations, Academic
Languages : en
Pages : 166
Book Description
Parkinson's Disease, Second Edition
Author: Ronald F. Pfeiffer
Publisher: CRC Press
ISBN: 1439807140
Category : Science
Languages : en
Pages : 1335
Book Description
In recent years, considerable advances have been made in our knowledge and understanding of Parkinson's disease (PD). In particular, there has been an explosion of information regarding genetic contributions to the etiology of PD and an increased awareness of the importance of the non-motor features of the disease. Theories regarding the pathogenesis and pathophysiology of PD have also been refined, and new treatment modalities and advances implemented. Reflecting these changes, this second edition features new chapters devoted to genetic aspects of PD, non-motor features of the disease, and aspects of the pathophysiology, pathogenesis, and treatment of PD.
Publisher: CRC Press
ISBN: 1439807140
Category : Science
Languages : en
Pages : 1335
Book Description
In recent years, considerable advances have been made in our knowledge and understanding of Parkinson's disease (PD). In particular, there has been an explosion of information regarding genetic contributions to the etiology of PD and an increased awareness of the importance of the non-motor features of the disease. Theories regarding the pathogenesis and pathophysiology of PD have also been refined, and new treatment modalities and advances implemented. Reflecting these changes, this second edition features new chapters devoted to genetic aspects of PD, non-motor features of the disease, and aspects of the pathophysiology, pathogenesis, and treatment of PD.